Injury Recovery Protocol

An integrated regenerative approach to chronic tendinopathy, slow-healing soft-tissue injuries, and post-surgical recovery — combining ALIV’s PRP for Athletes & Recovery with targeted peptide support and structured rehabilitation.

At a Glance

What it targets: Chronic tendinopathy, slow-healing soft-tissue injuries, post-surgical recovery, and the tissue-level drivers of repeated injury.

Who it’s for: Active adults with persistent tendon or joint pain that hasn’t resolved with rest, physiotherapy, and painkillers. Post-surgical recovery clients. Weekend athletes with recurrent injuries. Anyone wanting to exhaust regenerative options before surgery.

How it works: Physician-supervised combination of ALIV’s PRP for Athletes & Recovery, targeted regenerative peptide support, and structured rehab.

What to expect: Pain reduction and improved function typically emerge through the early and building phases. Structural tendon and soft-tissue healing builds across the sustained phase — tendons heal slowly by their nature.

Who This Protocol Is For

Tendinopathy and chronic soft-tissue injuries are common in active populations — cross-sectional Indian data shows around 39% of sports participants affected. Many of our clients arrive specifically researching PRP injection, sports injury treatment, knee or shoulder pain treatment, ligament tear, tendon injury, or post-surgical recovery in India — and want a comprehensive regenerative approach rather than another round of NSAIDs and physiotherapy. The frustrating reality is that many injuries don’t resolve with the standard rest-NSAIDs-physiotherapy approach. They become stuck.

This protocol was built for you if:

• Chronic knee, shoulder, elbow, hip, or Achilles pain that persists despite months of rest and physiotherapy
• Tendinopathy (patellar, rotator cuff, tennis/golfer’s elbow, Achilles) that keeps recurring when you return to activity
• Post-surgical recovery where healing has stalled or where you want to accelerate tissue regeneration
• Weekend athlete who keeps getting hurt — same injuries, different weeks
• Dependent on NSAIDs to stay active and looking for a better long-term approach
• Active adult over 40 dealing with the cumulative toll of years of sport or physically demanding work

Important note for competitive athletes: Several peptides used in this protocol — BPC-157 and TB-500 — are prohibited by the World Anti-Doping Agency (WADA). If you compete under WADA jurisdiction, ALIV will design a WADA-compliant version using only the orthopedic regenerative therapies and structured rehabilitation.

How It Works — The ALIV Approach

Most chronic soft-tissue injuries are stuck in a failed healing response — enough damage to stay painful, not enough acute signal for full repair. ALIV’s approach combines several mechanisms: concentrated biological growth factors delivered to the injured tissue, systemic peptide support, and the metabolic and lifestyle conditions that make healing happen.

Layer 1 — ALIV’s Orthopedic Regenerative Therapy

This protocol builds on a therapy ALIV has been delivering for years. PRP for Athletes & Recovery delivers concentrated growth factors — PDGF, TGF-β, VEGF, IGF-1, and others — directly into the injured tissue, signalling repair the failed healing response hasn’t. This is the interventional core of the protocol.

Layer 2 — Regenerative Peptide Options

Several peptides target distinct aspects of tissue healing as physician-selected options based on injury type and chronicity.

BPC-157 — a synthetic pentadecapeptide originally isolated from human gastric juice. Preclinical evidence shows tendon, ligament, muscle, and bone healing acceleration through angiogenesis, fibroblast migration, and growth factor signalling. Honest framing: a 2025 systematic review confirmed the preclinical evidence base is substantial but human clinical evidence is limited — BPC-157 is not FDA-approved.

TB-500 (Thymosin Beta-4 fragment) — thymosin beta-4 is a peptide concentrated in platelets and wound fluid where it acts as a master regulator of cellular repair through actin sequestration, cell migration, and angiogenesis. Used in injury recovery for tissue-repair orchestration; same evidence-base caveats as BPC-157.

GHK-Cu — a copper-binding tripeptide that regulates dermal fibroblast activity, matrix metalloproteinases, and collagen synthesis. Particularly relevant where connective tissue remodelling is the goal — chronic tendinopathy involves disordered collagen architecture that GHK-Cu may help re-organise.

Layer 3 — Diagnostic Precision and Structured Rehabilitation

Before any protocol is started, your ALIV physician runs a comprehensive workup — clinical examination, imaging review, blood work covering metabolic and inflammatory markers, and assessment of systemic factors blocking your healing (insulin resistance, nutrient deficiency, sleep disruption). Equally critical: no regenerative protocol replaces structured rehabilitation. The biological layers accelerate the environment for healing; structured progressive loading actually rebuilds tendon and tissue.

What to Expect

Injury recovery timelines are tissue-specific. Tendons heal slowly by their nature — they are poorly vascularised and biologically designed for slow turnover. Ligaments and muscle vary in healing pace. Honest expectations are part of the protocol.

Individual results vary based on injury type and chronicity, age, metabolic and hormonal status, adherence to rehabilitation, and other factors. ALIV does not guarantee specific outcomes.

What’s Involved

Before starting, your ALIV medical team runs the comprehensive diagnostic assessment described above and designs a protocol specifically for you. Not every client needs all the layers. The protocol is not initiated in the presence of active infection at or near the injured site, undiagnosed cancer, active autoimmune flare affecting the injured tissue, pregnancy or breastfeeding, or where surgical management is the more appropriate first step.

The Lifestyle Layer — What Chronic Injury Survivors Miss

Most chronic injuries are not purely biomechanical. Systemic factors quietly block tissue repair and are frequently overlooked in standard orthopedic care.

Metabolic and inflammatory context: elevated insulin, chronic inflammation, and poor metabolic health directly impair tissue healing. The diagnostic layer screens for this; coordination with the Metabolic Reset Protocol runs alongside where indicated.

Nutritional foundation: tissue repair requires adequate protein intake — the single biggest dietary lever for healing, most often under-dosed. Common supplementation: Vitamin C, Magnesium, Vitamin D, Omega-3, Glycine — tailored to assessment.

Sleep and recovery physiology: tissue repair happens during sleep. Where sleep is disrupted, the Sleep Protocol coordinates with this design.

Rehabilitation and progressive loading: mandatory. Tendons need appropriately dosed load to remodel. Return to activity is guided by clinical response, not calendar dates.

Stop reaching for the NSAID bottle: chronic NSAID use suppresses the inflammatory signalling required for healing — short-term relief at the cost of slower, less complete repair.

Frequently Asked Questions

How is this different from just getting a PRP injection?

PRP is one layer of this protocol — important, and for some clients the most impactful. But PRP alone often doesn’t resolve chronic tendinopathy because the systemic and lifestyle factors blocking healing remain unaddressed. The protocol combines biological intervention with the metabolic and rehabilitation context that rebuilds tissue.

Does PRP work for knee pain or arthritis?

Evidence varies by indication. For tennis elbow, patellar and rotator cuff tendinopathy, and Achilles tendinopathy, multiple systematic reviews support PRP, particularly for chronic cases not responding to physiotherapy. For mild-to-moderate knee osteoarthritis, randomised trials show PRP can reduce pain and improve function. PRP does not regrow lost cartilage or repair full-thickness tears. It works best when tissue can still respond — chronic but not end-stage.

Can chronic tendinopathy be cured?

Many chronic tendinopathies can be substantially resolved with the right combination — regenerative biological signalling, structured progressive loading, and correction of systemic factors blocking healing. End-stage tendon tears with structural damage may need surgical repair. Earlier intervention, better outcome.

I’m a competitive athlete — can I do this protocol?

BPC-157 and TB-500 are both prohibited by WADA. If you compete under WADA jurisdiction, the full protocol is not appropriate. ALIV can design a WADA-compliant version using only the regenerative therapies and structured rehabilitation.

What’s the evidence for BPC-157 and TB-500?

Preclinical evidence is strong — decades of animal studies showing tendon, ligament, muscle, and bone healing acceleration. Human clinical evidence is limited; recent systematic reviews note the gap between preclinical promise and rigorous human trials. Use at ALIV is investigational with full informed consent.

Could this work for post-surgical recovery?

Yes — a common use case, particularly after ACL reconstruction, rotator cuff repair, meniscal repair, or Achilles repair. Timed to recovery phase and coordinated with your operating surgeon.

Who should NOT do this protocol?

Active infection at or near the injured site; untreated malignancy; active autoimmune flare affecting the injured tissue; pregnancy or breastfeeding; clients where surgical management is the more appropriate first step.

Take the Next Step

Chronic soft-tissue injuries wear people down — pain, lost function, repeated physiotherapy cycles, creeping NSAID use. There’s a better path.

To find out if the Injury Recovery Protocol is right for you, speak with our medical team:

• Pune (Bund Garden): +91 77199 88811
• Mumbai (Khar West): +91 98220 93069

Or book a consultation through alivtherapy.in.

Research References

1. Vasireddi N, Hahamyan H, Salata MJ, et al. Emerging use of BPC-157 in orthopaedic sports medicine: a systematic review. HSS J. 2025;21(4):15563316251355551. PMID: 40756949

2. Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med. 2005;11(9):421-429. PMID: 16099219

3. Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987. PMID: 29986520

4. Singh A, Sharan L, Shankhapal VR, Shenoy S. From shoulder to ankle: a cross-sectional study of tendinopathy prevalence across the athletic population. J Sports Rehabil Sci. 2025;3(1):1-10. DOI: 10.32598/JSRS.2505.1084

Disclaimer

The information on this page is for educational purposes only and is not intended as medical advice. ALIV therapies are not intended to diagnose, treat, cure, or prevent any disease, including any musculoskeletal condition. This protocol is integrative supportive care, not a replacement for specialist orthopedic surgical management where indicated. Outcomes vary significantly between individuals — ALIV does not guarantee specific outcomes. The peptides referenced (BPC-157, TB-500, GHK-Cu) are not FDA-approved and are accessed in India via compounding pharmacies; informed consent and physician monitoring are essential. BPC-157 and TB-500 are prohibited by the World Anti-Doping Agency (WADA) — athletes competing under WADA jurisdiction must not use these compounds. Please consult a qualified healthcare professional before starting any therapy programme.